Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2004

Open Access 01-12-2004 | Review

Syndecans in tumor cell adhesion and signaling

Authors: DeannaLee M Beauvais, Alan C Rapraeger

Published in: Reproductive Biology and Endocrinology | Issue 1/2004

Login to get access

Abstract

Anchorage of cells to "heparin" – binding domains that are prevalent in extracellular matrix (ECM) components is thought to occur primarily through the syndecans, a four-member family of transmembrane heparan sulfate proteoglycans that communicate environmental cues from the ECM to the cytoskeleton and the signaling apparatus of the cell. Known activities of the syndecans trace to their highly conserved cytoplasmic domains and to their heparan sulfate chains, which can serve to regulate the signaling of growth factors and morphogens. However, several emerging studies point to critical roles for the syndecans' extracellular protein domains in tumor cell behavior to include cell adhesion and invasion. Although the mechanisms of these activities remain largely unknown, one possibility involves "co-receptor" interactions with integrins that may regulate integrin function and the cell adhesion-signaling phenotype. Thus, alterations in syndecan expression, leading to either overexpression or loss of expression, both of which take place in tumor cells, may have dramatic effects on tumor cell invasion.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994, 79: 1157-1164.PubMedCrossRef Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994, 79: 1157-1164.PubMedCrossRef
2.
go back to reference Domanico SZ, Pelletier AJ, Havran WL, Quaranta V: Integrin alpha 6A beta 1 induces CD81-dependent cell motility without engaging the extracellular matrix migration substrate. Mol Biol Cell. 1997, 8: 2253-2265.PubMedCentralPubMedCrossRef Domanico SZ, Pelletier AJ, Havran WL, Quaranta V: Integrin alpha 6A beta 1 induces CD81-dependent cell motility without engaging the extracellular matrix migration substrate. Mol Biol Cell. 1997, 8: 2253-2265.PubMedCentralPubMedCrossRef
3.
go back to reference Brassard DL, Maxwell E, Malkowski M, Nagabhushan TL, Kumar CC, Armstrong L: Integrin alpha(v)beta(3)-mediated activation of apoptosis. Exp Cell Res. 1999, 251: 33-45.PubMedCrossRef Brassard DL, Maxwell E, Malkowski M, Nagabhushan TL, Kumar CC, Armstrong L: Integrin alpha(v)beta(3)-mediated activation of apoptosis. Exp Cell Res. 1999, 251: 33-45.PubMedCrossRef
4.
go back to reference Kuzuya M, Satake S, Ramos MA, Kanda S, Koike T, Yoshino K, Ikeda S, Iguchi A: Induction of apoptotic cell death in vascular endothelial cells cultured in three-dimensional collagen lattice. Exp Cell Res. 1999, 248: 498-508.PubMedCrossRef Kuzuya M, Satake S, Ramos MA, Kanda S, Koike T, Yoshino K, Ikeda S, Iguchi A: Induction of apoptotic cell death in vascular endothelial cells cultured in three-dimensional collagen lattice. Exp Cell Res. 1999, 248: 498-508.PubMedCrossRef
5.
go back to reference Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA: Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol. 2001, 155: 459-470.PubMedCentralPubMedCrossRef Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA: Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol. 2001, 155: 459-470.PubMedCentralPubMedCrossRef
6.
go back to reference Bachelder RE, Marchetti A, Falcioni R, Soddu S, Mercurio AM: Activation of p53 function in carcinoma cells by the alpha6beta4 integrin. J Biol Chem. 1999, 274: 20733-20737.PubMedCrossRef Bachelder RE, Marchetti A, Falcioni R, Soddu S, Mercurio AM: Activation of p53 function in carcinoma cells by the alpha6beta4 integrin. J Biol Chem. 1999, 274: 20733-20737.PubMedCrossRef
7.
go back to reference Lewis JM, Truong TN, Schwartz MA: Integrins regulate the apoptotic response to DNA damage through modulation of p53. Proc Natl Acad Sci U S A. 2002, 99: 3627-3632.PubMedCentralPubMedCrossRef Lewis JM, Truong TN, Schwartz MA: Integrins regulate the apoptotic response to DNA damage through modulation of p53. Proc Natl Acad Sci U S A. 2002, 99: 3627-3632.PubMedCentralPubMedCrossRef
8.
go back to reference Iba K, Albrechtsen R, Gilpin B, Frohlich C, Loechel F, Zolkiewska A, Ishiguro K, Kojima T, Liu W, Langford JK, Sanderson RD, Brakebusch C, Fassler R, Wewer UM: The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol. 2000, 149: 1143-1156.PubMedCentralPubMedCrossRef Iba K, Albrechtsen R, Gilpin B, Frohlich C, Loechel F, Zolkiewska A, Ishiguro K, Kojima T, Liu W, Langford JK, Sanderson RD, Brakebusch C, Fassler R, Wewer UM: The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol. 2000, 149: 1143-1156.PubMedCentralPubMedCrossRef
9.
go back to reference Thodeti CK, Albrechtsen R, Grauslund M, Asmar M, Larsson C, Takada Y, Mercurio AM, Couchman JR, Wewer UM: ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J Biol Chem. 2003, 278: 9576-9584.PubMedCrossRef Thodeti CK, Albrechtsen R, Grauslund M, Asmar M, Larsson C, Takada Y, Mercurio AM, Couchman JR, Wewer UM: ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J Biol Chem. 2003, 278: 9576-9584.PubMedCrossRef
10.
go back to reference Ly DP, Zazzali KM, Corbett SA: De Novo Expression of the Integrin {alpha}5{beta}1 Regulates {alpha}v{beta}3-mediated Adhesion and Migration on Fibrinogen. J Biol Chem. 2003, 278: 21878-21885.PubMedCrossRef Ly DP, Zazzali KM, Corbett SA: De Novo Expression of the Integrin {alpha}5{beta}1 Regulates {alpha}v{beta}3-mediated Adhesion and Migration on Fibrinogen. J Biol Chem. 2003, 278: 21878-21885.PubMedCrossRef
11.
go back to reference Hodivala-Dilke KM, DiPersio CM, Kreidberg JA, Hynes RO: Novel roles for alpha3beta1 integrin as a regulator of cytoskeletal assembly and as a trans-dominant inhibitor of integrin receptor function in mouse keratinocytes. J Cell Biol. 1998, 142: 1357-1369.PubMedCentralPubMedCrossRef Hodivala-Dilke KM, DiPersio CM, Kreidberg JA, Hynes RO: Novel roles for alpha3beta1 integrin as a regulator of cytoskeletal assembly and as a trans-dominant inhibitor of integrin receptor function in mouse keratinocytes. J Cell Biol. 1998, 142: 1357-1369.PubMedCentralPubMedCrossRef
12.
go back to reference Blystone SD, Slater SE, Williams MP, Crow MT, Brown EJ: A molecular mechanism of integrin crosstalk: alphavbeta3 suppression of calcium/calmodulin-dependent protein kinase II regulates alpha5beta1 function. J Cell Biol. 1999, 145: 889-897.PubMedCentralPubMedCrossRef Blystone SD, Slater SE, Williams MP, Crow MT, Brown EJ: A molecular mechanism of integrin crosstalk: alphavbeta3 suppression of calcium/calmodulin-dependent protein kinase II regulates alpha5beta1 function. J Cell Biol. 1999, 145: 889-897.PubMedCentralPubMedCrossRef
13.
go back to reference Kiosses WB, Shattil SJ, Pampori N, Schwartz MA: Rac recruits high-affinity integrin alphavbeta3 to lamellipodia in endothelial cell migration. Nat Cell Biol. 2001, 3: 316-320.PubMedCrossRef Kiosses WB, Shattil SJ, Pampori N, Schwartz MA: Rac recruits high-affinity integrin alphavbeta3 to lamellipodia in endothelial cell migration. Nat Cell Biol. 2001, 3: 316-320.PubMedCrossRef
14.
go back to reference Tomatis D, Echtermayer F, Schober S, Balzac F, Retta SF, Silengo L, Tarone G: The muscle-specific laminin receptor alpha7 beta1 integrin negatively regulates alpha5 beta1 fibronectin receptor function. Exp Cell Res. 1999, 246: 421-432.PubMedCrossRef Tomatis D, Echtermayer F, Schober S, Balzac F, Retta SF, Silengo L, Tarone G: The muscle-specific laminin receptor alpha7 beta1 integrin negatively regulates alpha5 beta1 fibronectin receptor function. Exp Cell Res. 1999, 246: 421-432.PubMedCrossRef
15.
go back to reference Retta SF, Balzac F, Ferraris P, Belkin AM, Fassler R, Humphries MJ, De Leo G, Silengo L, Tarone G: beta1-integrin cytoplasmic subdomains involved in dominant negative function. Mol Biol Cell. 1998, 9: 715-731.PubMedCentralPubMedCrossRef Retta SF, Balzac F, Ferraris P, Belkin AM, Fassler R, Humphries MJ, De Leo G, Silengo L, Tarone G: beta1-integrin cytoplasmic subdomains involved in dominant negative function. Mol Biol Cell. 1998, 9: 715-731.PubMedCentralPubMedCrossRef
16.
go back to reference Sharma A, Askari JA, Humphries MJ, Jones EY, Stuart DI: Crystal structure of a heparin- and integrin-binding segment of human fibronectin. Embo J. 1999, 18: 1468-1479.PubMedCentralPubMedCrossRef Sharma A, Askari JA, Humphries MJ, Jones EY, Stuart DI: Crystal structure of a heparin- and integrin-binding segment of human fibronectin. Embo J. 1999, 18: 1468-1479.PubMedCentralPubMedCrossRef
17.
go back to reference Sanderson RD: Heparan sulfate proteoglycans in invasion and metastasis. Semin Cell Dev Biol. 2001, 12: 89-98.PubMedCrossRef Sanderson RD: Heparan sulfate proteoglycans in invasion and metastasis. Semin Cell Dev Biol. 2001, 12: 89-98.PubMedCrossRef
18.
go back to reference Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U: Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer. 2002, 2: 521-528.PubMedCrossRef Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U: Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer. 2002, 2: 521-528.PubMedCrossRef
19.
go back to reference Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 1999, 68: 729-777.PubMedCrossRef Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 1999, 68: 729-777.PubMedCrossRef
20.
go back to reference Cohen AR, Woods DF, Marfatia SM, Walther Z, Chishti AH, Anderson JM, Wood DF: Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J Cell Biol. 1998, 142: 129-138.PubMedCentralPubMedCrossRef Cohen AR, Woods DF, Marfatia SM, Walther Z, Chishti AH, Anderson JM, Wood DF: Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J Cell Biol. 1998, 142: 129-138.PubMedCentralPubMedCrossRef
21.
go back to reference Rapraeger AC, Ott VL: Molecular interactions of the syndecan core proteins. Curr Opin Cell Biol. 1998, 10: 620-628.PubMedCrossRef Rapraeger AC, Ott VL: Molecular interactions of the syndecan core proteins. Curr Opin Cell Biol. 1998, 10: 620-628.PubMedCrossRef
22.
go back to reference Hsueh YP, Roberts AM, Volta M, Sheng M, Roberts RG: Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans. J Neurosci. 2001, 21: 3764-3770.PubMed Hsueh YP, Roberts AM, Volta M, Sheng M, Roberts RG: Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans. J Neurosci. 2001, 21: 3764-3770.PubMed
23.
go back to reference Granes F, Urena JM, Rocamora N, Vilaro S: Ezrin links syndecan-2 to the cytoskeleton. J Cell Sci. 2000, 113: 1267-1276.PubMed Granes F, Urena JM, Rocamora N, Vilaro S: Ezrin links syndecan-2 to the cytoskeleton. J Cell Sci. 2000, 113: 1267-1276.PubMed
24.
go back to reference Hsueh YP, Yang FC, Kharazia V, Naisbitt S, Cohen AR, Weinberg RJ, Sheng M: Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses. J Cell Biol. 1998, 142: 139-151.PubMedCentralPubMedCrossRef Hsueh YP, Yang FC, Kharazia V, Naisbitt S, Cohen AR, Weinberg RJ, Sheng M: Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses. J Cell Biol. 1998, 142: 139-151.PubMedCentralPubMedCrossRef
25.
go back to reference Grootjans JJ, Zimmermann P, Reekmans G, Smets A, Degeest G, Durr J, David G: Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci U S A. 1997, 94: 13683-13688.PubMedCentralPubMedCrossRef Grootjans JJ, Zimmermann P, Reekmans G, Smets A, Degeest G, Durr J, David G: Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci U S A. 1997, 94: 13683-13688.PubMedCentralPubMedCrossRef
26.
go back to reference Ethell IM, Hagihara K, Miura Y, Irie F, Yamaguchi Y: Synbindin, A novel syndecan-2-binding protein in neuronal dendritic spines. J Cell Biol. 2000, 151: 53-68.PubMedCentralPubMedCrossRef Ethell IM, Hagihara K, Miura Y, Irie F, Yamaguchi Y: Synbindin, A novel syndecan-2-binding protein in neuronal dendritic spines. J Cell Biol. 2000, 151: 53-68.PubMedCentralPubMedCrossRef
27.
go back to reference Gao Y, Li M, Chen W, Simons M: Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J Cell Physiol. 2000, 184: 373-379.PubMedCrossRef Gao Y, Li M, Chen W, Simons M: Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J Cell Physiol. 2000, 184: 373-379.PubMedCrossRef
28.
go back to reference Horowitz A, Murakami M, Gao Y, Simons M: Phosphatidylinositol-4,5-bisphosphate mediates the interaction of syndecan-4 with protein kinase C. Biochemistry. 1999, 38: 15871-15877.PubMedCrossRef Horowitz A, Murakami M, Gao Y, Simons M: Phosphatidylinositol-4,5-bisphosphate mediates the interaction of syndecan-4 with protein kinase C. Biochemistry. 1999, 38: 15871-15877.PubMedCrossRef
29.
go back to reference Oh ES, Woods A, Lim ST, Theibert AW, Couchman JR: Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-bisphosphate coordinately regulate protein kinase C activity. J Biol Chem. 1998, 273: 10624-10629.PubMedCrossRef Oh ES, Woods A, Lim ST, Theibert AW, Couchman JR: Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4,5-bisphosphate coordinately regulate protein kinase C activity. J Biol Chem. 1998, 273: 10624-10629.PubMedCrossRef
30.
go back to reference Shin J, Lee W, Lee D, Koo BK, Han I, Lim Y, Woods A, Couchman JR, Oh ES: Solution structure of the dimeric cytoplasmic domain of syndecan-4. Biochemistry. 2001, 40: 8471-8478.PubMedCrossRef Shin J, Lee W, Lee D, Koo BK, Han I, Lim Y, Woods A, Couchman JR, Oh ES: Solution structure of the dimeric cytoplasmic domain of syndecan-4. Biochemistry. 2001, 40: 8471-8478.PubMedCrossRef
31.
go back to reference Lee D, Oh ES, Woods A, Couchman JR, Lee W: Solution structure of a syndecan-4 cytoplasmic domain and its interaction with phosphatidylinositol 4,5-bisphosphate. J Biol Chem. 1998, 273: 13022-13029.PubMedCrossRef Lee D, Oh ES, Woods A, Couchman JR, Lee W: Solution structure of a syndecan-4 cytoplasmic domain and its interaction with phosphatidylinositol 4,5-bisphosphate. J Biol Chem. 1998, 273: 13022-13029.PubMedCrossRef
33.
go back to reference Oh ES, Woods A, Couchman JR: Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J Biol Chem. 1997, 272: 8133-8136.PubMedCrossRef Oh ES, Woods A, Couchman JR: Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J Biol Chem. 1997, 272: 8133-8136.PubMedCrossRef
34.
go back to reference Oh ES, Woods A, Couchman JR: Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J Biol Chem. 1997, 272: 11805-11811.PubMedCrossRef Oh ES, Woods A, Couchman JR: Multimerization of the cytoplasmic domain of syndecan-4 is required for its ability to activate protein kinase C. J Biol Chem. 1997, 272: 11805-11811.PubMedCrossRef
35.
go back to reference Longley RL, Woods A, Fleetwood A, Cowling GJ, Gallagher JT, Couchman JR: Control of morphology, cytoskeleton and migration by syndecan-4. J Cell Sci. 1999, 112: 3421-3431.PubMed Longley RL, Woods A, Fleetwood A, Cowling GJ, Gallagher JT, Couchman JR: Control of morphology, cytoskeleton and migration by syndecan-4. J Cell Sci. 1999, 112: 3421-3431.PubMed
36.
37.
go back to reference Horowitz A, Simons M: Regulation of syndecan-4 phosphorylation in vivo. J Biol Chem. 1998, 273: 10914-10918.PubMedCrossRef Horowitz A, Simons M: Regulation of syndecan-4 phosphorylation in vivo. J Biol Chem. 1998, 273: 10914-10918.PubMedCrossRef
38.
go back to reference Horowitz A, Simons M: Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha. J Biol Chem. 1998, 273: 25548-25551.PubMedCrossRef Horowitz A, Simons M: Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha. J Biol Chem. 1998, 273: 25548-25551.PubMedCrossRef
39.
go back to reference Baciu PC, Saoncella S, Lee SH, Denhez F, Leuthardt D, Goetinck PF: Syndesmos, a protein that interacts with the cytoplasmic domain of syndecan-4, mediates cell spreading and actin cytoskeletal organization. J Cell Sci. 2000, 113 (Pt 2): 315-324.PubMed Baciu PC, Saoncella S, Lee SH, Denhez F, Leuthardt D, Goetinck PF: Syndesmos, a protein that interacts with the cytoplasmic domain of syndecan-4, mediates cell spreading and actin cytoskeletal organization. J Cell Sci. 2000, 113 (Pt 2): 315-324.PubMed
40.
go back to reference Greene DK, Tumova S, Couchman JR, Woods A: Syndecan-4 associates with alpha-actinin. J Biol Chem. 2003, 278: 7617-7623.PubMedCrossRef Greene DK, Tumova S, Couchman JR, Woods A: Syndecan-4 associates with alpha-actinin. J Biol Chem. 2003, 278: 7617-7623.PubMedCrossRef
41.
go back to reference Lebakken CS, Rapraeger AC: Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells. J Cell Biol. 1996, 132: 1209-1221.PubMedCrossRef Lebakken CS, Rapraeger AC: Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells. J Cell Biol. 1996, 132: 1209-1221.PubMedCrossRef
42.
go back to reference Lebakken CS, McQuade KJ, Rapraeger AC: Syndecan-1 signals independently of beta1 integrins during Raji cell spreading. Exp Cell Res. 2000, 259: 315-325.PubMedCrossRef Lebakken CS, McQuade KJ, Rapraeger AC: Syndecan-1 signals independently of beta1 integrins during Raji cell spreading. Exp Cell Res. 2000, 259: 315-325.PubMedCrossRef
43.
44.
45.
go back to reference Klass CM, Couchman JR, Woods A: Control of extracellular matrix assembly by syndecan-2 proteoglycan. J Cell Sci. 2000, 113: 493-506.PubMed Klass CM, Couchman JR, Woods A: Control of extracellular matrix assembly by syndecan-2 proteoglycan. J Cell Sci. 2000, 113: 493-506.PubMed
46.
go back to reference Ethell IM, Yamaguchi Y: Cell Surface Heparan Sulfate Proteoglycan Syndecan-2 Induces the Maturation of Dendritic Spines in Rat Hippocampal Neurons. J Cell Biol. 1999, 144: 575-586.PubMedCentralPubMedCrossRef Ethell IM, Yamaguchi Y: Cell Surface Heparan Sulfate Proteoglycan Syndecan-2 Induces the Maturation of Dendritic Spines in Rat Hippocampal Neurons. J Cell Biol. 1999, 144: 575-586.PubMedCentralPubMedCrossRef
47.
go back to reference Ethell IM, Irie F, Kalo MS, Couchman JR, Pasquale EB, Yamaguchi Y: EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron. 2001, 31: 1001-1013.PubMedCrossRef Ethell IM, Irie F, Kalo MS, Couchman JR, Pasquale EB, Yamaguchi Y: EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron. 2001, 31: 1001-1013.PubMedCrossRef
48.
go back to reference Granes F, Garcia R, Casaroli-Marano RP, Castel S, Rocamora N, Reina M, Urena JM, Vilaro S: Syndecan-2 induces filopodia by active cdc42Hs. Exp Cell Res. 1999, 248: 439-456.PubMedCrossRef Granes F, Garcia R, Casaroli-Marano RP, Castel S, Rocamora N, Reina M, Urena JM, Vilaro S: Syndecan-2 induces filopodia by active cdc42Hs. Exp Cell Res. 1999, 248: 439-456.PubMedCrossRef
49.
go back to reference Poullet P, Gautreau A, Kadare G, Girault JA, Louvard D, Arpin M: Ezrin interacts with focal adhesion kinase and induces its activation independently of cell-matrix adhesion. J Biol Chem. 2001, 276: 37686-37691.PubMedCrossRef Poullet P, Gautreau A, Kadare G, Girault JA, Louvard D, Arpin M: Ezrin interacts with focal adhesion kinase and induces its activation independently of cell-matrix adhesion. J Biol Chem. 2001, 276: 37686-37691.PubMedCrossRef
50.
go back to reference Jeong J, Han I, Lim Y, Kim J, Park I, Woods A, Couchman JR, Oh ES: Rat embryo fibroblasts require both the cell-binding and the heparin-binding domains of fibronectin for survival. Biochem J. 2001, 356: 531-537.PubMedCentralPubMedCrossRef Jeong J, Han I, Lim Y, Kim J, Park I, Woods A, Couchman JR, Oh ES: Rat embryo fibroblasts require both the cell-binding and the heparin-binding domains of fibronectin for survival. Biochem J. 2001, 356: 531-537.PubMedCentralPubMedCrossRef
51.
go back to reference Wilcox-Adelman SA, Denhez F, Goetinck PF: Syndecan-4 modulates focal adhesion kinase phosphorylation. J Biol Chem. 2002, 277: 32970-32977.PubMedCrossRef Wilcox-Adelman SA, Denhez F, Goetinck PF: Syndecan-4 modulates focal adhesion kinase phosphorylation. J Biol Chem. 2002, 277: 32970-32977.PubMedCrossRef
52.
go back to reference Kim J, Han I, Kim Y, Kim S, Oh ES: C-terminal heparin-binding domain of fibronectin regulates integrin-mediated cell spreading but not the activation of mitogen-activated protein kinase. Biochem J. 2001, 360: 239-245.PubMedCentralPubMedCrossRef Kim J, Han I, Kim Y, Kim S, Oh ES: C-terminal heparin-binding domain of fibronectin regulates integrin-mediated cell spreading but not the activation of mitogen-activated protein kinase. Biochem J. 2001, 360: 239-245.PubMedCentralPubMedCrossRef
53.
go back to reference Kinnunen A, Niemi M, Kinnunen T, Kaksonen M, Nolo R, Rauvala H: Heparan sulphate and HB-GAM (heparin-binding growth-associated molecule) in the development of the thalamocortical pathway of rat brain. Eur J Neurosci. 1999, 11: 491-502.PubMedCrossRef Kinnunen A, Niemi M, Kinnunen T, Kaksonen M, Nolo R, Rauvala H: Heparan sulphate and HB-GAM (heparin-binding growth-associated molecule) in the development of the thalamocortical pathway of rat brain. Eur J Neurosci. 1999, 11: 491-502.PubMedCrossRef
54.
go back to reference Kinnunen A, Kinnunen T, Kaksonen M, Nolo R, Panula P, Rauvala H: N-syndecan and HB-GAM (heparin-binding growth-associated molecule) associate with early axonal tracts in the rat brain. Eur J Neurosci. 1998, 10: 635-648.PubMedCrossRef Kinnunen A, Kinnunen T, Kaksonen M, Nolo R, Panula P, Rauvala H: N-syndecan and HB-GAM (heparin-binding growth-associated molecule) associate with early axonal tracts in the rat brain. Eur J Neurosci. 1998, 10: 635-648.PubMedCrossRef
55.
go back to reference Kinnunen T, Raulo E, Nolo R, Maccarana M, Lindahl U, Rauvala H: Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J Biol Chem. 1996, 271: 2243-2248.PubMedCrossRef Kinnunen T, Raulo E, Nolo R, Maccarana M, Lindahl U, Rauvala H: Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J Biol Chem. 1996, 271: 2243-2248.PubMedCrossRef
56.
go back to reference Kinnunen T, Kaksonen M, Saarinen J, Kalkkinen N, Peng HB, Rauvala H: Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J Biol Chem. 1998, 273: 10702-10708.PubMedCrossRef Kinnunen T, Kaksonen M, Saarinen J, Kalkkinen N, Peng HB, Rauvala H: Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J Biol Chem. 1998, 273: 10702-10708.PubMedCrossRef
57.
go back to reference Pavlov I, Voikar V, Kaksonen M, Lauri SE, Hienola A, Taira T, Rauvala H: Role of heparin-binding growth-associated molecule (HB-GAM) in hippocampal LTP and spatial learning revealed by studies on overexpressing and knockout mice. Mol Cell Neurosci. 2002, 20: 330-342.PubMedCrossRef Pavlov I, Voikar V, Kaksonen M, Lauri SE, Hienola A, Taira T, Rauvala H: Role of heparin-binding growth-associated molecule (HB-GAM) in hippocampal LTP and spatial learning revealed by studies on overexpressing and knockout mice. Mol Cell Neurosci. 2002, 20: 330-342.PubMedCrossRef
58.
go back to reference Kaksonen M, Pavlov I, Voikar V, Lauri SE, Hienola A, Riekki R, Lakso M, Taira T, Rauvala H: Syndecan-3-deficient mice exhibit enhanced LTP and impaired hippocampus-dependent memory. Mol Cell Neurosci. 2002, 21: 158-172.PubMedCrossRef Kaksonen M, Pavlov I, Voikar V, Lauri SE, Hienola A, Riekki R, Lakso M, Taira T, Rauvala H: Syndecan-3-deficient mice exhibit enhanced LTP and impaired hippocampus-dependent memory. Mol Cell Neurosci. 2002, 21: 158-172.PubMedCrossRef
59.
go back to reference Lauri SE, Kaukinen S, Kinnunen T, Ylinen A, Imai S, Kaila K, Taira T, Rauvala H: Reg1ulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J Neurosci. 1999, 19: 1226-1235.PubMed Lauri SE, Kaukinen S, Kinnunen T, Ylinen A, Imai S, Kaila K, Taira T, Rauvala H: Reg1ulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J Neurosci. 1999, 19: 1226-1235.PubMed
60.
go back to reference Rapraeger A, Jalkanen M, Bernfield M: Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells. J Cell Biol. 1986, 103: 2683-2696.PubMedCrossRef Rapraeger A, Jalkanen M, Bernfield M: Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells. J Cell Biol. 1986, 103: 2683-2696.PubMedCrossRef
61.
go back to reference Kim CW, Goldberger OA, Gallo RL, Bernfield M: Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell. 1994, 5: 797-805.PubMedCentralPubMedCrossRef Kim CW, Goldberger OA, Gallo RL, Bernfield M: Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol Biol Cell. 1994, 5: 797-805.PubMedCentralPubMedCrossRef
62.
go back to reference Sanderson RD, Bernfield M: Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. Proc Natl Acad Sci U S A. 1988, 85: 9562-9566.PubMedCentralPubMedCrossRef Sanderson RD, Bernfield M: Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia. Proc Natl Acad Sci U S A. 1988, 85: 9562-9566.PubMedCentralPubMedCrossRef
63.
go back to reference Sun D, McAlmon KR, Davies JA, Bernfield M, Hay ED: Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. Int J Dev Biol. 1998, 42: 733-736.PubMed Sun D, McAlmon KR, Davies JA, Bernfield M, Hay ED: Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. Int J Dev Biol. 1998, 42: 733-736.PubMed
65.
go back to reference Bayer-Garner I, Dilday B, Sanderson R, Smoller B: Acantholysis and spongiosis are associated with loss of syndecan-1 expression. J Cutan Pathol. 2001, 28: 135-139.PubMedCrossRef Bayer-Garner I, Dilday B, Sanderson R, Smoller B: Acantholysis and spongiosis are associated with loss of syndecan-1 expression. J Cutan Pathol. 2001, 28: 135-139.PubMedCrossRef
66.
go back to reference Leppa S, Mali M, Miettinen HM, Jalkanen M: Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci U S A. 1992, 89: 932-936.PubMedCentralPubMedCrossRef Leppa S, Mali M, Miettinen HM, Jalkanen M: Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells. Proc Natl Acad Sci U S A. 1992, 89: 932-936.PubMedCentralPubMedCrossRef
67.
go back to reference Kato M, Saunders S, Nguyen H, Bernfield M: Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell. 1995, 6: 559-576.PubMedCentralPubMedCrossRef Kato M, Saunders S, Nguyen H, Bernfield M: Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell. 1995, 6: 559-576.PubMedCentralPubMedCrossRef
68.
go back to reference Leppa S, Harkonen P, Jalkanen M: Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells. Cell Regul. 1991, 2: 1-11.PubMedCentralPubMed Leppa S, Harkonen P, Jalkanen M: Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells. Cell Regul. 1991, 2: 1-11.PubMedCentralPubMed
69.
go back to reference Leppa S, Vleminckx K, Van Roy F, Jalkanen M: Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent. J Cell Sci. 1996, 109: 1393-1403.PubMed Leppa S, Vleminckx K, Van Roy F, Jalkanen M: Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent. J Cell Sci. 1996, 109: 1393-1403.PubMed
70.
go back to reference Soukka T, Pohjola J, Inki P, Happonen RP: Reduction of syndecan-1 expression is associated with dysplastic oral epithelium. J Oral Pathol Med. 2000, 29: 308-313.PubMedCrossRef Soukka T, Pohjola J, Inki P, Happonen RP: Reduction of syndecan-1 expression is associated with dysplastic oral epithelium. J Oral Pathol Med. 2000, 29: 308-313.PubMedCrossRef
71.
go back to reference Inki P, Stenback F, Grenman S, Jalkanen M: Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J Pathol. 1994, 172: 349-355.PubMedCrossRef Inki P, Stenback F, Grenman S, Jalkanen M: Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J Pathol. 1994, 172: 349-355.PubMedCrossRef
72.
go back to reference Rintala M, Inki P, Klemi P, Jalkanen M, Grenman S: Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma. Gynecol Oncol. 1999, 75: 372-378.PubMedCrossRef Rintala M, Inki P, Klemi P, Jalkanen M, Grenman S: Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma. Gynecol Oncol. 1999, 75: 372-378.PubMedCrossRef
73.
go back to reference Nakanishi K, Yoshioka N, Oka K, Hakura A: Reduction of syndecan-1 mRNA in cervical-carcinoma cells is involved with the 3' untranslated region. Int J Cancer. 1999, 80: 527-532.PubMedCrossRef Nakanishi K, Yoshioka N, Oka K, Hakura A: Reduction of syndecan-1 mRNA in cervical-carcinoma cells is involved with the 3' untranslated region. Int J Cancer. 1999, 80: 527-532.PubMedCrossRef
74.
go back to reference Numa F, Hirabayashi K, Kawasaki K, Sakaguchi Y, Sugino N, Suehiro Y, Suminami Y, Hirakawa H, Umayahara K, Nawata S, Ogata H, Kato H: Syndecan-1 expression in cancer of the uterine cervix: association with lymph node metastasis. Int J Oncol. 2002, 20: 39-43.PubMed Numa F, Hirabayashi K, Kawasaki K, Sakaguchi Y, Sugino N, Suehiro Y, Suminami Y, Hirakawa H, Umayahara K, Nawata S, Ogata H, Kato H: Syndecan-1 expression in cancer of the uterine cervix: association with lymph node metastasis. Int J Oncol. 2002, 20: 39-43.PubMed
75.
go back to reference Hirabayashi K, Numa F, Suminami Y, Murakami A, Murakami T, Kato H: Altered proliferative and metastatic potential associated with increased expression of syndecan-1. Tumour Biol. 1998, 19: 454-463.PubMedCrossRef Hirabayashi K, Numa F, Suminami Y, Murakami A, Murakami T, Kato H: Altered proliferative and metastatic potential associated with increased expression of syndecan-1. Tumour Biol. 1998, 19: 454-463.PubMedCrossRef
76.
go back to reference Anttonen A, Kajanti M, Heikkila P, Jalkanen M, Joensuu H: Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer. 1999, 79: 558-564.PubMedCentralPubMedCrossRef Anttonen A, Kajanti M, Heikkila P, Jalkanen M, Joensuu H: Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer. 1999, 79: 558-564.PubMedCentralPubMedCrossRef
77.
go back to reference Inki P, Joensuu H, Grenman R, Klemi P, Jalkanen M: Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer. 1994, 70: 319-323.PubMedCentralPubMedCrossRef Inki P, Joensuu H, Grenman R, Klemi P, Jalkanen M: Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer. 1994, 70: 319-323.PubMedCentralPubMedCrossRef
78.
go back to reference Nackaerts K, Verbeken E, Deneffe G, Vanderschueren B, Demedts M, David G: Heparan sulfate proteoglycan expression in human lung-cancer cells. Int J Cancer. 1997, 74: 335-345.PubMedCrossRef Nackaerts K, Verbeken E, Deneffe G, Vanderschueren B, Demedts M, David G: Heparan sulfate proteoglycan expression in human lung-cancer cells. Int J Cancer. 1997, 74: 335-345.PubMedCrossRef
79.
go back to reference Pulkkinen JO, Penttinen M, Jalkanen M, Klemi P, Grenman R: Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol. 1997, 117: 312-315.PubMedCrossRef Pulkkinen JO, Penttinen M, Jalkanen M, Klemi P, Grenman R: Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol. 1997, 117: 312-315.PubMedCrossRef
80.
go back to reference Klatka J: Syndecan-1 expression in laryngeal cancer. Eur Arch Otorhinolaryngol. 2002, 259: 115-118.PubMedCrossRef Klatka J: Syndecan-1 expression in laryngeal cancer. Eur Arch Otorhinolaryngol. 2002, 259: 115-118.PubMedCrossRef
81.
go back to reference Kumar-Singh S, Jacobs W, Dhaene K, Weyn B, Bogers J, Weyler J, Van Marck E: Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome. J Pathol. 1998, 186: 300-305.PubMedCrossRef Kumar-Singh S, Jacobs W, Dhaene K, Weyn B, Bogers J, Weyler J, Van Marck E: Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome. J Pathol. 1998, 186: 300-305.PubMedCrossRef
82.
83.
go back to reference Matsumoto A, Ono M, Fujimoto Y, Gallo RL, Bernfield M, Kohgo Y: Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer. 1997, 74: 482-491.PubMedCrossRef Matsumoto A, Ono M, Fujimoto Y, Gallo RL, Bernfield M, Kohgo Y: Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer. 1997, 74: 482-491.PubMedCrossRef
84.
go back to reference Fujiya M, Watari J, Ashida T, Honda M, Tanabe H, Fujiki T, Saitoh Y, Kohgo Y: Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Jpn J Cancer Res. 2001, 92: 1074-1081.PubMedCrossRef Fujiya M, Watari J, Ashida T, Honda M, Tanabe H, Fujiki T, Saitoh Y, Kohgo Y: Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Jpn J Cancer Res. 2001, 92: 1074-1081.PubMedCrossRef
85.
go back to reference Levy P, Munier A, Baron-Delage S, Chastre E, Gespach C, Capeau J, Cherqui G: [Oncogenic activation of p21ras or pp60c-src in human colonic Caco-2 cells induces post-translation alterations of syndecan-1]. Bull Cancer. 1997, 84: 235-237.PubMed Levy P, Munier A, Baron-Delage S, Chastre E, Gespach C, Capeau J, Cherqui G: [Oncogenic activation of p21ras or pp60c-src in human colonic Caco-2 cells induces post-translation alterations of syndecan-1]. Bull Cancer. 1997, 84: 235-237.PubMed
86.
go back to reference Levy P, Munier A, Baron-Delage S, Di Gioia Y, Gespach C, Capeau J, Cherqui G: Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes. Br J Cancer. 1996, 74: 423-431.PubMedCentralPubMedCrossRef Levy P, Munier A, Baron-Delage S, Di Gioia Y, Gespach C, Capeau J, Cherqui G: Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes. Br J Cancer. 1996, 74: 423-431.PubMedCentralPubMedCrossRef
87.
go back to reference Park H, Kim Y, Lim Y, Han I, Oh ES: Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J Biol Chem. 2002, 277: 29730-29736.PubMedCrossRef Park H, Kim Y, Lim Y, Han I, Oh ES: Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J Biol Chem. 2002, 277: 29730-29736.PubMedCrossRef
88.
go back to reference Mundhenke C, Meyer K, Drew S, Friedl A: Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol. 2002, 160: 185-194.PubMedCentralPubMedCrossRef Mundhenke C, Meyer K, Drew S, Friedl A: Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol. 2002, 160: 185-194.PubMedCentralPubMedCrossRef
89.
go back to reference Crescimanno C, Marzioni D, Paradinas FJ, Schrurs B, Muhlhauser J, Todros T, Newlands E, David G, Castellucci M: Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast. J Pathol. 1999, 189: 600-608.PubMedCrossRef Crescimanno C, Marzioni D, Paradinas FJ, Schrurs B, Muhlhauser J, Todros T, Newlands E, David G, Castellucci M: Expression pattern alterations of syndecans and glypican-1 in normal and pathological trophoblast. J Pathol. 1999, 189: 600-608.PubMedCrossRef
90.
go back to reference Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, Cumberledge S, Bernfield M: Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet. 2000, 25: 329-332.PubMedCrossRef Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, Cumberledge S, Bernfield M: Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet. 2000, 25: 329-332.PubMedCrossRef
91.
go back to reference Conejo JR, Kleeff J, Koliopanos A, Matsuda K, Zhu ZW, Goecke H, Bicheng N, Zimmermann A, Korc M, Friess H, Buchler MW: Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int J Cancer. 2000, 88: 12-20.PubMedCrossRef Conejo JR, Kleeff J, Koliopanos A, Matsuda K, Zhu ZW, Goecke H, Bicheng N, Zimmermann A, Korc M, Friess H, Buchler MW: Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int J Cancer. 2000, 88: 12-20.PubMedCrossRef
92.
go back to reference Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C: Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer. 2001, 95: 1-6.PubMedCrossRef Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C: Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer. 2001, 95: 1-6.PubMedCrossRef
93.
go back to reference Burbach BJ, Friedl A, Mundhenke C, Rapraeger AC: Syndecan-1 accumulates in lysosomes of poorly differentiated breast carcinoma cells. Matrix Biol. 2003, 22: 163-177.PubMedCrossRef Burbach BJ, Friedl A, Mundhenke C, Rapraeger AC: Syndecan-1 accumulates in lysosomes of poorly differentiated breast carcinoma cells. Matrix Biol. 2003, 22: 163-177.PubMedCrossRef
94.
go back to reference Stanley MJ, Stanley MW, Sanderson RD, Zera R: Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol. 1999, 112: 377-383.PubMed Stanley MJ, Stanley MW, Sanderson RD, Zera R: Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol. 1999, 112: 377-383.PubMed
95.
go back to reference Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, Galligioni E, Doglioni C: High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer. 2003, 98: 474-483.PubMedCrossRef Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, Galligioni E, Doglioni C: High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer. 2003, 98: 474-483.PubMedCrossRef
96.
go back to reference Liu W, Litwack ED, Stanley MJ, Langford JK, Lander AD, Sanderson RD: Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J Biol Chem. 1998, 273: 22825-22832.PubMedCrossRef Liu W, Litwack ED, Stanley MJ, Langford JK, Lander AD, Sanderson RD: Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J Biol Chem. 1998, 273: 22825-22832.PubMedCrossRef
97.
go back to reference Ohtake T, Fujimoto Y, Ikuta K, Saito H, Ohhira M, Ono M, Kohgo Y: Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells. Br J Cancer. 1999, 81: 393-403.PubMedCentralPubMedCrossRef Ohtake T, Fujimoto Y, Ikuta K, Saito H, Ohhira M, Ono M, Kohgo Y: Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells. Br J Cancer. 1999, 81: 393-403.PubMedCentralPubMedCrossRef
98.
go back to reference Beauvais DM, Rapraeger AC: Syndecan-1-mediated cell spreading requires signaling by alpha(v)beta(3) integrins in human breast carcinoma cells. Exp Cell Res. 2003, 286: 219-232.PubMedCrossRef Beauvais DM, Rapraeger AC: Syndecan-1-mediated cell spreading requires signaling by alpha(v)beta(3) integrins in human breast carcinoma cells. Exp Cell Res. 2003, 286: 219-232.PubMedCrossRef
99.
go back to reference McFall AJ, Rapraeger AC: Identification of an adhesion site within the syndecan-4 extracellular protein domain. J Biol Chem. 1997, 272: 12901-12904.PubMedCrossRef McFall AJ, Rapraeger AC: Identification of an adhesion site within the syndecan-4 extracellular protein domain. J Biol Chem. 1997, 272: 12901-12904.PubMedCrossRef
100.
go back to reference McFall AJ, Rapraeger AC: Characterization of the high affinity cell-binding domain in the cell surface proteoglycan syndecan-4. J Biol Chem. 1998, 273: 28270-28276.PubMedCrossRef McFall AJ, Rapraeger AC: Characterization of the high affinity cell-binding domain in the cell surface proteoglycan syndecan-4. J Biol Chem. 1998, 273: 28270-28276.PubMedCrossRef
101.
go back to reference Mali M, Andtfolk H, Miettinen HM, Jalkanen M: Suppression of tumor cell growth by syndecan-1 ectodomain. J Biol Chem. 1994, 269: 27795-27798.PubMed Mali M, Andtfolk H, Miettinen HM, Jalkanen M: Suppression of tumor cell growth by syndecan-1 ectodomain. J Biol Chem. 1994, 269: 27795-27798.PubMed
102.
go back to reference Gulyas M, Hjerpe A: Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. J Pathol. 2003, 199: 479-487.PubMedCrossRef Gulyas M, Hjerpe A: Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. J Pathol. 2003, 199: 479-487.PubMedCrossRef
103.
go back to reference Roskams T, De Vos R, David G, Van Damme B, Desmet V: Heparan sulphate proteoglycan expression in human primary liver tumours. J Pathol. 1998, 185: 290-297.PubMedCrossRef Roskams T, De Vos R, David G, Van Damme B, Desmet V: Heparan sulphate proteoglycan expression in human primary liver tumours. J Pathol. 1998, 185: 290-297.PubMedCrossRef
104.
go back to reference Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, Goetinck P: Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest. 2001, 107: R9-R14.PubMedCentralPubMedCrossRef Echtermeyer F, Streit M, Wilcox-Adelman S, Saoncella S, Denhez F, Detmar M, Goetinck P: Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest. 2001, 107: R9-R14.PubMedCentralPubMedCrossRef
105.
go back to reference Shimazu A, Bachchu MA, Morishita M, Noshiro M, Kato Y, Iwamoto Y: Expression of syndecan-2, -4, and fibroblast growth factor receptor type 1 in human periodontal ligament fibroblasts and down-regulation of these membrane proteins during maturation in culture. J Dent Res. 1999, 78: 1791-1799.PubMedCrossRef Shimazu A, Bachchu MA, Morishita M, Noshiro M, Kato Y, Iwamoto Y: Expression of syndecan-2, -4, and fibroblast growth factor receptor type 1 in human periodontal ligament fibroblasts and down-regulation of these membrane proteins during maturation in culture. J Dent Res. 1999, 78: 1791-1799.PubMedCrossRef
106.
go back to reference Yung S, Woods A, Chan TM, Davies M, Williams JD, Couchman JR: Syndecan-4 up-regulation in proliferative renal disease is related to microfilament organization. Faseb J. 2001, 15: 1631-1633.PubMed Yung S, Woods A, Chan TM, Davies M, Williams JD, Couchman JR: Syndecan-4 up-regulation in proliferative renal disease is related to microfilament organization. Faseb J. 2001, 15: 1631-1633.PubMed
107.
go back to reference Iba K, Albrechtsen R, Gilpin BJ, Loechel F, Wewer UM: Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol. 1999, 154: 1489-1501.PubMedCentralPubMedCrossRef Iba K, Albrechtsen R, Gilpin BJ, Loechel F, Wewer UM: Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol. 1999, 154: 1489-1501.PubMedCentralPubMedCrossRef
108.
go back to reference Khan MY, Jaikaria NS, Frenz DA, Villanueva G, Newman SA: Structural changes in the NH2-terminal domain of fibronectin upon interaction with heparin. Relationship to matrix-driven translocation. J Biol Chem. 1988, 263: 11314-11318.PubMed Khan MY, Jaikaria NS, Frenz DA, Villanueva G, Newman SA: Structural changes in the NH2-terminal domain of fibronectin upon interaction with heparin. Relationship to matrix-driven translocation. J Biol Chem. 1988, 263: 11314-11318.PubMed
109.
go back to reference Yagami-Hiromasa T, Sato T, Kurisaki T, Kamijo K, Nabeshima Y, Fujisawa-Sehara A: A metalloprotease-disintegrin participating in myoblast fusion. Nature. 1995, 377: 652-656.PubMedCrossRef Yagami-Hiromasa T, Sato T, Kurisaki T, Kamijo K, Nabeshima Y, Fujisawa-Sehara A: A metalloprotease-disintegrin participating in myoblast fusion. Nature. 1995, 377: 652-656.PubMedCrossRef
110.
go back to reference Kurisaki T, Masuda A, Osumi N, Nabeshima Y, Fujisawa-Sehara A: Spatially- and temporally-restricted expression of meltrin alpha (ADAM12) and beta (ADAM19) in mouse embryo. Mech Dev. 1998, 73: 211-215.PubMedCrossRef Kurisaki T, Masuda A, Osumi N, Nabeshima Y, Fujisawa-Sehara A: Spatially- and temporally-restricted expression of meltrin alpha (ADAM12) and beta (ADAM19) in mouse embryo. Mech Dev. 1998, 73: 211-215.PubMedCrossRef
111.
go back to reference Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, Wewer UM: A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem. 1998, 273: 157-166.PubMedCrossRef Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, Wewer UM: A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem. 1998, 273: 157-166.PubMedCrossRef
112.
go back to reference Galliano MF, Huet C, Frygelius J, Polgren A, Wewer UM, Engvall E: Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha-actinin-2, is required for myoblast fusion. J Biol Chem. 2000, 275: 13933-13939.PubMedCrossRef Galliano MF, Huet C, Frygelius J, Polgren A, Wewer UM, Engvall E: Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha-actinin-2, is required for myoblast fusion. J Biol Chem. 2000, 275: 13933-13939.PubMedCrossRef
114.
go back to reference Kang Q, Cao Y, Zolkiewska A: Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells. Biochem J. 2000, 352 (Pt 3): 883-892.PubMedCentralPubMed Kang Q, Cao Y, Zolkiewska A: Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells. Biochem J. 2000, 352 (Pt 3): 883-892.PubMedCentralPubMed
115.
go back to reference Kang Q, Cao Y, Zolkiewska A: Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells. J Biol Chem. 2001, 276: 24466-24472.PubMedCrossRef Kang Q, Cao Y, Zolkiewska A: Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells. J Biol Chem. 2001, 276: 24466-24472.PubMedCrossRef
116.
go back to reference Suzuki A, Kadota N, Hara T, Nakagami Y, Izumi T, Takenawa T, Sabe H, Endo T: Meltrin alpha cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src. Oncogene. 2000, 19: 5842-5850.PubMedCrossRef Suzuki A, Kadota N, Hara T, Nakagami Y, Izumi T, Takenawa T, Sabe H, Endo T: Meltrin alpha cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src. Oncogene. 2000, 19: 5842-5850.PubMedCrossRef
117.
go back to reference Itano N, Oguri K, Nakanishi H, Okayama M: Membrane-intercalated proteoglycan of a stroma-inducing clone from Lewis lung carcinoma binds to fibronectin via its heparan sulfate chains. J Biochem (Tokyo). 1993, 114: 862-873. Itano N, Oguri K, Nakanishi H, Okayama M: Membrane-intercalated proteoglycan of a stroma-inducing clone from Lewis lung carcinoma binds to fibronectin via its heparan sulfate chains. J Biochem (Tokyo). 1993, 114: 862-873.
118.
go back to reference Nakanishi H, Oguri K, Takenaga K, Hosoda S, Okayama M: Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells. Lab Invest. 1994, 70: 324-332.PubMed Nakanishi H, Oguri K, Takenaga K, Hosoda S, Okayama M: Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells. Lab Invest. 1994, 70: 324-332.PubMed
119.
go back to reference Kusano Y, Oguri K, Nagayasu Y, Munesue S, Ishihara M, Saiki I, Yonekura H, Yamamoto H, Okayama M: Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Exp Cell Res. 2000, 256: 434-444.PubMedCrossRef Kusano Y, Oguri K, Nagayasu Y, Munesue S, Ishihara M, Saiki I, Yonekura H, Yamamoto H, Okayama M: Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Exp Cell Res. 2000, 256: 434-444.PubMedCrossRef
120.
go back to reference Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M: The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones. Biochem J. 2002, 363: 201-209.PubMedCentralPubMedCrossRef Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M: The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones. Biochem J. 2002, 363: 201-209.PubMedCentralPubMedCrossRef
121.
go back to reference Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Tsuzuki S, Nakamura E, Kusugami K, Saito H, Muramatsu T: Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions. J Biol Chem. 2000, 275: 5249-5252.PubMedCrossRef Ishiguro K, Kadomatsu K, Kojima T, Muramatsu H, Tsuzuki S, Nakamura E, Kusugami K, Saito H, Muramatsu T: Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions. J Biol Chem. 2000, 275: 5249-5252.PubMedCrossRef
122.
go back to reference Kim Y, Park H, Lim Y, Han I, Kwon HJ, Woods A, Oh ES: Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells. Oncogene. 2003, 22: 826-830.PubMedCrossRef Kim Y, Park H, Lim Y, Han I, Kwon HJ, Woods A, Oh ES: Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells. Oncogene. 2003, 22: 826-830.PubMedCrossRef
123.
go back to reference Contreras HR, Fabre M, Granes F, Casaroli-Marano R, Rocamora N, Herreros AG, Reina M, Vilaro S: Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype. Biochem Biophys Res Commun. 2001, 286: 742-751.PubMedCrossRef Contreras HR, Fabre M, Granes F, Casaroli-Marano R, Rocamora N, Herreros AG, Reina M, Vilaro S: Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype. Biochem Biophys Res Commun. 2001, 286: 742-751.PubMedCrossRef
Metadata
Title
Syndecans in tumor cell adhesion and signaling
Authors
DeannaLee M Beauvais
Alan C Rapraeger
Publication date
01-12-2004
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2004
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-2-3

Other articles of this Issue 1/2004

Reproductive Biology and Endocrinology 1/2004 Go to the issue